Saliva Collection & Diagnostics Market Size, Growth, Trends | Report 2022-2030
The global saliva collection & diagnostics market was estimated at USD 1,645.2 million in 2021 and it is expected to surpass around USD 5514.02 million by 2030, poised to grow at a CAGR of 11.4% from 2022 to 2030.
Oral fluid samples are most frequently used in diagnostics due to the simplicity of collection. The diagnostic potential of salivary biomolecules clearly illustrates the health status of an individual with respect to a wide variety of diseases. Numerous salivary proteins are most efficiently used as biological markers for diagnostics so as to monitor the development of various medical disorders as well as track the efficacy of therapeutic regimes.
An extensive rise in disease research studies along with a growing number of new product launches is expected to leverage the market during the forecast period. For instance, in June 2021, Naveris, Inc. announced the launch of its new saliva-based test which is capable to detect neck and head cancer.
The salivary analysis offers reliable inferences in research on diseases such as viral infections, bacterial infections, oncology, toxicology, forensics, autoimmune diseases and endocrinology. In addition, the gradual rise in the use of oral fluid samples for diagnostic & research applications, rising emphasis on non-invasive sample collection procedures, and positive approach of patients to this type of sample collection is also estimated to drive the market growth during the forecast period. For instance, in August 2022, according to a study conducted by a group of researchers in Israel, saliva samples can be utilized for the diagnosis of PTSD (post-traumatic stress disorder).
U.S. Food and Drug Administration (FDA) recommended a saliva-direct COVID-19 diagnostic test as a new and efficient diagnostic method over nasopharyngeal swab method to diagnose COVID-19 infection to make up for the short supply of COVID-19 diagnostic reagents. This situation heavily boosted the market during the pandemic situation.
Moreover, diagnostic technological advancements in cases of infant saliva collection are also anticipated to drive market growth during the forecast period. For instance, the kits developed by Oasis Diagnostics for infants facilitate sample collection with a simple design by being able to mesmerize infants during the procedure.
An increase in the number of ailments, number of clinical trials are rising the need for the growth of the saliva collection devices market. The utility rate of point-of-care test kits is on the rise due to mandated testing of forensics, drug abuse testing for employees, driving staff, and the population at risk of occupational hazards. For instance, in April 2022, a group of researchers developed a saliva test for the detection of glaucoma in high-risk individuals.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1,645.2 million |
| Revenue Forecast by 2030 | USD 5514.02 million |
| Growth rate from 2022 to 2030 | CAGR of 11.4% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Saliva Type, Application, End use, Region |
| Companies Covered |
OraSure Technologies, Draeger, Securetec Detektions-Systeme, Oranoxis, Lin-Zhi International, Oasis Diagnostics, Cell Projects, Prometheus bio, Quest Diagnostics, Abbott Laboratories, Premier Biotech, Neogen Corporation, Guangzhou Wondfo Biotech, Salimetrics. |
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Saliva Collection & Diagnostics Market
5.1. COVID-19 Landscape: Saliva Collection & Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Saliva Collection & Diagnostics Market, By Saliva Type
8.1. Saliva Collection & Diagnostics Market, by Saliva Type, 2022-2030
8.1.1 Whole Saliva
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Glandular Saliva
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Other
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Saliva Collection & Diagnostics Market, By Application
9.1. Saliva Collection & Diagnostics Market, by Application, 2022-2030
9.1.1. Disease Diagnostics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Forensic applications
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Research
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Saliva Collection & Diagnostics Market, By End use
10.1. Saliva Collection & Diagnostics Market, by End use, 2022-2030
10.1.1. Dentistry
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Pharmaceutical & Biotechnology companies
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Research Institutes
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Saliva Collection & Diagnostics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End use (2017-2030)
Chapter 12. Company Profiles
12.1. OraSure Technologies
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Draeger
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Securetec Detektions-Systeme
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Oranoxis
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Lin-Zhi International
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Oasis Diagnostics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cell Projects
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Prometheus bio
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Quest Diagnostics
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Abbott Laboratories
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers